Status:
COMPLETED
Impact of Continuing Medical Education (CME) Insulin Program
Lead Sponsor:
HealthPartners Institute
Collaborating Sponsors:
International Diabetes Center at Park Nicollet
Eli Lilly and Company
Conditions:
Diabetes
Eligibility:
All Genders
25+ years
Brief Summary
The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement...
Detailed Description
We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. Specifically, we will address the followin...
Eligibility Criteria
Inclusion
- primary care provider attending CME training
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
294 Patients enrolled
Trial Details
Trial ID
NCT00824603
Start Date
June 1 2006
End Date
August 1 2009
Last Update
December 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Diabetes Center
Minneapolis, Minnesota, United States, 55416